From: The fraction of life years lost after diagnosis (FLYLAD): a person-centred measure of cancer burden
 | All cancers | Localised at diagnosis | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aboriginal | Matched non-Aboriginal# | Aboriginal | Matched non-Aboriginal# | |||||||||||||
N | % | Mean | 95% CIs | N | % | Mean | 95% CIs | N | % | Mean | 95% CIs | N | % | Mean | 95% CIs | |
Risk | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Age at diagnosis | 777 | 100.0% | 57.7 | 56.6–58.8 | 777 | 100.0% | 58.5 | 57.4–59.5 | 289 | 100.0% | 58.4 | 56.5–60.3 | 390 | 100.0% | 57.8 | 56.2–59.3 |
LYAR |  |  | 31.0 | 30.0–32.0 |  |  | 30.3 | 29.3–31.3 |  |  | 30.4 | 28.7–32.2 |  |  | 30.9 | 29.5–32.4 |
Loss | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Cancer deaths24-months* | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Age at deathcancer 24-months | 346 | 44.5% | 60.4 | 58.9–61.9 | 224 | 28.8% | 63.5 | 61.6–65.4 | 51 | 17.6% | 63.0 | 58.5–67.5 | 40 | 10.3% | 64.4 | 59.3–69.4 |
YLLcancer 24-months |  |  | 12.7 | 11.5–13.9 |  |  | 7.4 | 6.5–8.4 |  |  | 4.7 | 3.3–6.0 |  |  | 2.6 | 1.7–3.5 |
Fraction of loss: risk | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
FLYLADcancer 24-months |  |  | 0.44 | 0.40–0.47 |  |  | 0.28 | 0.25–0.31 |  |  | 0.17 | 0.13–0.21 |  |  | 0.10 | 0.07–0.13 |
 | Regional spread at diagnosis | Distant/unknown spread at diagnosis | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aboriginal | Matched non-Aboriginal# | Aboriginal | Matched non-Aboriginal# | |||||||||||||
N | % | Mean | 95% CIs | N | % | Mean | 95% CIs | N | % | Mean | 95% CIs | N | % | Mean | 95% CIs | |
Risk | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Age at diagnosis | 155 | 100.0% | 55.5 | 53.2–57.8 | 132 | 100.0% | 57.9 | 55.4–60.5 | 333 | 100.0% | 58.1 | 56.4–59.8 | 255 | 100.0% | 59.8 | 57.9–61.7 |
LYAR |  |  | 32.8 | 30.7–34.9 |  |  | 30.7 | 28.4–33.0 |  |  | 30.6 | 29.1–32.1 |  |  | 29.1 | 27.4–30.8 |
Loss | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Cancer deaths 24-months* | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Age at deathcancer 24-months | 67 | 43.2% | 58.5 | 55.2–61.8 | 37 | 28.0% | 63.4 | 58.4–68.3 | 228 | 68.5% | 60.4 | 58.5–62.3 | 147 | 57.6% | 63.3 | 61.0–65.6 |
YLLcancer 24-months |  |  | 13.0 | 10.3–15.7 |  |  | 7.2 | 4.9–9.6 |  |  | 19.5 | 17.7–21.4 |  |  | 15.0 | 13.0–16.9 |
Fraction of loss: risk | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
FLYLADcancer 24-months |  |  | 0.42 | 0.35–0.50 |  |  | 0.27 | 0.20–0.35 |  |  | 0.68 | 0.63–0.72 |  |  | 0.57 | 0.51–0.63 |